标题：Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
摘要：Correction to:
Scientific Reports 10.1038/s41598-021-91657-7, published online 08 June 2021
The original version of this Article contained errors in Table 4, where the P value was omitted and the “Adjusted HR (95% CI)
a” value for “ECOG PS” was incorrectly assigned. The correct and incorrect values appear below.
Incorrect:
Characteristics
HR (95% CI)
a
P value
Adjusted HR (95% CI)
a
P value
Smoking status
NS
Reference
0.51 (0.29–0.90)
C/FS
1.59 (0.95–2.65)
0.079
ECOG PS
2–4
Reference
0–1
0.52 (0.30–0.90)
0.019
Correct:
Characteristics
HR (95% CI)
a
P value
Adjusted HR (95% CI)
a
P value
Smoking status
NS
Reference
C/FS
1.59 (0.95–2.65)
0.079
ECOG PS
2–4
Reference
0–1
0.52 (0.30–0.90)
0.019
0.51 (0.29–0.90)
0.020
The original Article has been corrected.
